Eumovate^® (Clobetasone Butyrate 0.05% Cream and Ointment)

  Content:

COMPLIANCE

• Reasons for treatment failure in atopic eczema:
• failure to use the topical corticosteroid due to fear of real or imagined side-effects
• under prescribing/failure to use sufficient quantity
• failure to renew prescription in time.

• It is very important that patients/caregivers understand the safety and potential side effects for moderate potency topical corticosteroids such as Eumovate®. Misconceptions about commonly prescribed topical corticosteroid preparations among parents/caregivers include:
• 44% graded hydrocortisone as a potent steroid.
• 42% did not grade betamethasone valerate 0.1% as potent.
• 29% graded clobetasol butyrate 0.05% (Eumovate®) as potent.
• 12% graded clobetasol butyrate 0.05% (Eumovate®) as weak.

[Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of atopic dermatitis. Clin Exp Dermatol. 2003 Sep;28(5):549-53.]

• Patient education on topical steroids is clearly needed

Next:   Side Effects, Safety and Risks